Global Gonorrhea Testing Kits Market Research Report 2021

Gonorrhea Testing Kits is the procedure to test if the patient have the Gonorrhea

The global Gonorrhea Testing Kits market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Gonorrhea Testing Kits volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Gonorrhea Testing Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Gonorrhea Testing Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Nucleic Acid Amplification (NAA)
Gram Stain
Enzyme-linked immunosorbent assay (ELISA)
Gonorrhea Culture
Rapid Test

Segment by Application
Hospitals
Pathology Lab
Pointof Care Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott
ADI/American Diagnostica
Agilent Technologies
Chrono-Log
Corgenix
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
International Technidyne/Nexus DX
Kreatech/Leica
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens